In April this year Metallobio’s Chief Scientific Advisor and Co-founder Professor Jim Thomas will be speaking at the highly regarded ESCMID (European Society of Clinical Microbiology and Infectious Diseases) conference. He shall be participating in a Pipeline Corner session on Monday 14th, speaking in a conference space dedicated to therapeutics currently in motion in the R&D pipeline. Professor Thomas’ contribution shall highlight how the contributions of SMEs and Universities contribute to the global antibiotic pipeline. Professor Thomas’ depth of knowledge and unique experience with MetalloBio ensure an authoritative perspective on the impact that effective academic collaboration can provide to those involved in antibiotic development. Accompanying him shall be, MetalloBio’s CEO, Michael Murray.